日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Redefining Clinical Perspectives on MCS: Toward an Evidence-Based, Multisystem Model. Comment on Jacques, L. Multiple Chemical Sensitivity: A Clinical Perspective. Brain Sci. 2024, 14, 1261

重新定义多重化学敏感性的临床视角:迈向循证的多系统模型。评述 Jacques, L. 的《多重化学敏感性:临床视角》(Brain Sci. 2024, 14, 1261)。

Psaradellis, Elaine

A Qualitative Exploration of Policy, Institutional, and Social Misconceptions Faced by Individuals with Multiple Chemical Sensitivity

对多重化学物质过敏症患者面临的政策、制度和社会误解的定性探索

Yousufzai, Susan J; Psaradellis, Elaine; Peris, Rohini; Barakat, Caroline

Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly

对接受培哚普利和阿托伐他汀联合治疗的轻度至中度高血压患者的 CONFIDENCE II、PROTECT I、SHAKE THE HABIT I 和 SHAKE THE HABIT II 观察性研究进行事后分析

Sampalis, John S; Psaradellis, Eliofotisti; Stutz, Melissa; Rickard, Jenaya; Rampakakis, Emmanouil

Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study

巴西圣保罗带状疱疹疾病负担评估:一项单中心临床流行病学研究

Toniolo-Neto, João; Psaradellis, Eliofotisti; Karellis, Angela; Rampakakis, Emmanouil; Rockett, Talita Y; Sampalis, John S; Johnson, Kelly D; Monsanto, Homero A; Acosta, Camilo J

Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry

银屑病关节炎最小疾病活动指数的真实世界验证:一项来自前瞻性、观察性生物治疗注册研究的分析

Rahman, Proton; Zummer, Michel; Bessette, Louis; Baer, Philip; Haraoui, Boulos; Chow, Andrew; Kelsall, John; Kapur, Suneil; Rampakakis, Emmanouil; Psaradellis, Eliofotisti; Lehman, Allen J; Nantel, Francois; Osborne, Brendan; Tkaczyk, Cathy

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis

加拿大生物制剂治疗登记研究(BioTRAC):一项针对接受英夫利昔单抗治疗强直性脊柱炎患者的多中心、前瞻性观察性研究

Rahman, Proton; Choquette, Denis; Bensen, William G; Khraishi, Majed; Chow, Andrew; Zummer, Michel; Shaikh, Saeed; Sheriff, Maqbool; Dixit, Sanjay; Sholter, Dalton; Psaradellis, Eliofotisti; Sampalis, John S; Letourneau, Vincent; Lehman, Allen J; Nantel, François; Rampakakis, Emmanouil; Otawa, Susan; Shawi, May

Do patients with active RA have differences in disease activity and perceptions if anti-TNF naïve versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial

活动性类风湿关节炎患者若未接受过抗TNF治疗,其疾病活动度和感知是否存在差异?阿达木单抗优化试验的基线结果

Pope, Janet; Thorne, J Carter; Haraoui, Boulos Paul; Psaradellis, Eliofotisti; Sampalis, John

Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study

BIO K+ CL1285 降低抗生素相关性腹泻疗效的一项安慰剂对照双盲随机多中心研究

Sampalis, John; Psaradellis, Eliofotisti; Rampakakis, Emmanouil

Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial)

孟鲁司特作为吸入性皮质类固醇的辅助疗法用于哮喘治疗(SAS试验)

FitzGerald, J Mark; Foucart, Sylvain; Coyle, Stephen; Sampalis, John; Haine, Denis; Psaradellis, Eliofotisti; McIvor, R Andrew

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)

在哮喘合并过敏性鼻炎患者的治疗中,孟鲁司特可作为吸入性皮质类固醇单药治疗或吸入性皮质类固醇联合长效β2受体激动剂的附加疗法(RADAR试验)。

Keith, Paul K; Koch, Caroline; Djandji, Michel; Bouchard, Jacques; Psaradellis, Eliofotisti; Sampalis, John S; Schellenberg, R Robert; McIvor, R Andrew